Immuron IMRN
NASDAQ IMRN
$0.93 -0.04 (-4.02%)
As of: Oct 22, 2026 · 12:46 PM EDT

Immuron (IMRN) Other non-cash items (2018 - 2021)

Updated

Analysis

Immuron (IMRN) Other non-cash items (2018 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,169.70 Bn 1,138.29 Bn 19.71 Bn
2 Johnson & Johnson 647.50 Bn 567.36 Bn 17.30 Bn
3 AbbVie 504.26 Bn 477.37 Bn 12.70 Bn
4 Merck 368.38 Bn 322.75 Bn 12.21 Bn
5 Novartis Ag 303.14 Bn 267.13 Bn 11.24 Bn
6 Astrazeneca 268.24 Bn 241.93 Bn 12.86 Bn
7 Amgen 242.50 Bn 197.90 Bn 7.24 Bn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn
9 Pfizer 173.14 Bn 119.78 Bn 10.94 Bn
10 Immuron 6.91 Mn -10.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 456,059.77
Sep 1, 2020 -18,883.00
Jun 30, 2020 -12,376.31
Dec 31, 2019 -62,015.00
Aug 30, 2019 -62,015.00
Dec 31, 2018 -316,380.00
API Access

Immuron Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=IMRN&period=max&api_key=YOUR_API_KEY